References
- Bergeron MG, Ke D, Ménard C, et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med. 2000;343:175–179.
- Bergeron MG. Revolutionizing the practice of medicine through rapid (< 1h) DNA-based diagnostics. Clin Invest Med. 2008;31:E265–E271.
- Bissonnette L, Bergeron MG. Next revolution in the molecular theranostics of infectious diseases: microfabricated systems for personalized medicine. Expert Rev Mol Diagn. 2006;6:433–450.
- Bissonnette L, Bergeron MG. Infectious disease management through point-of-care personalized medicine molecular diagnostic technologies. J Pers Med. 2012;2:50–70.
- Bissonnette L, Bergeron MG. Multiparametric technologies for the diagnosis of syndromic infections. Clin Microbiol Newslett. 2012;34:159–168.
- Personalized Medicine Coalition. The case for personalized medicine, 4th edition, 2014. Available at: http://www.personalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/pmc_case_for_personalized_medicine.pdf [Last accessed December 2016]
- United States 114th Congress. 21st Century Cures Act. Available at: http://docs.house.gov/billsthisweek/20161128/CPRT-114-HPRT-RU00-SAHR34.pdf [Last accessed January 2017]
- Miller LF, Mata M. Precision medicine in infectious diseases: changing the treatment paradigm for bacterial infections to end the antimicrobial resistance crisis. J Precision Med. 2016 Jan/Feb 44–50. [Last accessed December 2016] Available at: http://www.thejournalofprecisionmedicine.com/wp-content/uploads/2015/10/MILLER-MATA.pdf
- Daar AS, Thorsteinsdóttir H, Martin DK, et al. Top ten biotechnologies for improving health in developing countries. Nat Genet. 2002;32:229–232.
- Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Available at: https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf [Last accessed March 2017]
- Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance - the need for global solutions. Lancet Infect Dis. 2013;13:1057–1098.
- Perez KK, Olsen RJ, Musick WL, et al. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med. 2013;137:1247–1254.
- The White House (Washington). National action plan for combating antibiotic-resistant bacteria. Available at: https://obamawhitehouse.archives.gov/sites/default/files/docs/national_action_plan_for_combating_antibotic-resistant_bacteria.pdf [Last accessed March 2017]
- United Nations. Draft political declaration of the high-level meeting of the General Assembly on antimicrobial resistance. Available at: http://www.un.org/pga/71/wp-content/uploads/sites/40/2016/09/DGACM_GAEAD_ESCAB-AMR-Draft-Political-Declaration-1616108E.pdf [Last accessed November 2016]
- World Bank. Drug-resistant infections: a threat to our economic future (Discussion Draft). Available at: http://pubdocs.worldbank.org/en/527731474225046104/AMR-Discussion-Draft-Sept18updated.pdf [Last accessed November 2016]
- World Health Organization. WHO publishes list of bacteria for which new antibiotics are urgently needed. Available at: http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/[Last accessed March 2017]
- Bissonnette L, Bergeron MG. POC tests in microbial diagnostics: current status. In Sails A, Tan YW. Current and emerging technologies for the diagnosis of microbial infections. Methods Microbiol. 2015;42:87–110.
- Bissonnette L, Chapdelaine S, Peytavi R, et al. A revolutionary microfluidic stand-alone platform (GenePOC) for nucleic-acid based point-of-care diagnostics. In: Kost GJ, Corbin CM, Editors. Global point of care - Strategies for disasters, emergencies, and public health resilience. Washington: AACC Press; 2015. p. 235–247.
- Gandham P. POCT tests - Would they meet the goal of the clinical microbiology laboratories. Int J Curr Microbiol App Sci. 2015;4:508–524.
- Huckle D. The impact of new trends in POCTs for companion diagnostics, non-invasive testing and molecular diagnostics. Expert Rev Mol Diagn. 2015;15:815–827.
- Larsson A, Greig-Pylypczuk R, Huisman A. The state of point-of-care testing: a European perspective. Upsala J Med Sci. 2015;120:1–10.
- Luppa PB, Bietenbeck A, Beaudoin C, et al. Clinically relevant analytical techniques, organizational concepts for application and future perspectives of point-of-care testing. Biotechnol Adv. 2016;34:139–160.
- Shaw JLV. Practical challenges related to point of care testing. Practical Lab Med. 2016;4:22–29.
- Natoli L, Guy RJ, Shephard M, et al. “I do feel like a scientist at times”: a qualitative study of the acceptability of molecular point-of-care testing for chlamydia and gonorrhoea to primary care professionals in a remote high STI burden setting. Plos One. 2015;10(12):e0145993.
- Quinn AD, Dixon D, Meenan BJ. Barriers to hospital-based clinical adoption of point-of-care testing (POCT): a systematic narrative review. Crit Rev Clin Lab Sci. 2016;53:1–12.
- Siegel JD, Rhinehart E, Jackson M, et al., and the Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf [Last accessed November 2016]
- Hardy V, Thompson M, Alto W, et al. Exploring the barriers and facilitators to use of point of care tests in family medicine clinics in the United States. BMC Fam Pract. 2016;17:149.
- Clinical Laboratory Improvement Amendments (CLIA). Available at: http://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA [Last accessed November 2016]
- Shawar R, Weissfeld AS. FDA regulation of clinical microbiology diagnostic devices. J Clin Microbiol. 2011;49:S80–S84.
- Gubbins PO, Klepser ME, Dering-Anderson AM, et al. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy. J Am Pharm Assoc. 2014;54:163–171.
- Ammirati EB. Bringing novel technologies to market: addressing Food and Drug Administration, Clinical Laboratory Improvement Amendment, and international regulatory challenges for in vitro diagnostics. In: Kost GJ, Corbin CM, Editors. Global point of care - Strategies for disasters, emergencies, and public health resilience. Washington: AACC Press; 2015. p. 585–593.
- Centers for Medicare and Medicaid Services (U.S. Department of Health and Human Services). Tests granted waived status under CLIA. Available at: http://www.cms.hhs.gov/CLIA/downloads/waivetbl.pdf [Last accessed November 2016]
- United States Food and Drug Administration. CLIA - Tests waived by FDA from January 2000 to present. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfclia/testswaived.cfm [Last accessed November 2016]
- Goldenberg SD, Edgeworth JD. The Enigma ML FluAB-RSV assay: a fully automated molecular test for the rapid detection of influenza A, B and respiratory syncytial viruses in respiratory specimens. Expert Rev Mol Diagn. 2015;15:23–32.
- Bergeron MG, Ouellette M. Preventing antibiotic resistance using rapid DNA-based diagnostic tests. Infect Control Hosp Epidemiol. 1998;19:560–564.
- Pant Pai N, Vadnais C, Denkinger C, et al. Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries. Plos Med. 2012;9:e1001306.
- Schito M, Peter TF, Cavanaugh S, et al. Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis. J Infect Dis. 2012;205:S169–180.
- Zwerling A, Dowdy D. Economic evaluations of point of care testing strategies for active tuberculosis. Expert Rev Pharmacoecon Outcomes Res. 2013;13:313–325.
- Pai M, Ghiasi M, Pant Pai N. Point-of-care diagnostic testing in global health: what is the point? Microbe. 2015;10:103–107.
- Beavers Vandiver TK. Collaborative medicine: weaving microbiology into point-of-care clinical responsiveness. In: Kost GJ, Corbin CM, Editors. Global point of care - Strategies for disasters, emergencies, and public health resilience. Washington: AACC Press; 2015. p. 277–289.
- Brendish NJ, Schiff HF, Clark TW. Point-of-care testing for respiratory viruses in adults: the current landscape and future potential. J Infection. 2015;71:501–510.
- Rudolf J, Lewandrowski K. Point-of-care testing in the emergency department: impact on operations and outcomes. In: Kost GJ, Corbin CM, Editors. Global point of care - Strategies for disasters, emergencies, and public health resilience. Washington: AACC Press; 2015. p. 69–82.
- Mohd Hanafiah K, Garcia M, Anderson D. Point-of-care testing and the control of infectious diseases. Biomark Med. 2013;7:333–347.
- Caliendo AM, Gilbert DN, Ginocchio CC, et al. (for the Infectious Diseases Society of America), Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis. 2013;57(S3):S139–170.
- Abou Tayoun AN, Burchard PR, Malik I, et al. Democratizing molecular diagnostics for the developing world. Am J Clin Pathol. 2014;141:17–24.
- Rompalo AM, Hsieh Y-H, Hogan T, et al. Point-of-care tests for sexually transmissible infections: what do ‘end users’ want? Sex Health. 2013;10:541–545.
- Gaydos C, Hardick J. Point of care diagnostics for sexually transmitted infections: perspectives and advances. Expert Rev Anti Infect Ther. 2014;12:657–672.
- Brook G. The performance of non-NAAT point-of-care (POC) tests and rapid NAAT tests for chlamydia and gonorrhoea infections. An assessment of currently available assays. Sex Transm Infect. 2015;91:539–544.
- Sharma S, Zapatero-Rodriguez J, Estrela P, et al. Point-of-care diagnostics in low resource settings: present status and future role of microfluidics. Biosensors. 2015;5:577–601.
- Beal SG, Assarzadegan N, Rand KH. Sample-to-answer molecular infectious disease assays: clinical implications, limitations and potential. Expert Rev Mol Diagn. 2016;16:323–341.
- Su W, Gao X, Jiang L, et al. Microfluidic platform towards point-of-care diagnostics in infectious diseases. J Chromatogr A. 2015;1377:13–26.
- Borysiak MD, Thompson MJ, Posner JD. Translating diagnostic assays from the laboratory to the clinic: analytical and clinical metrics for device development and evaluation. Lab Chip. 2016;16:1293–1313.
- Bayer Healthcare LLC Ascensia® CONTOUR® blood glucose monitoring system - User guide. Available at: http://pdfstream.manualsonline.com/f/f202613b-5bd2-4e38-a1b3-982620d7cc2d.pdf [Last accessed March 2017]
- Ginocchio CC. HIV-1 viral load testing. Lab Med. 2001;32:142–152.
- Yagupsky P, Nolte FS. Quantitative aspects of septicemia. Clin Microbiol Rev. 1990;3:269–279.
- Delanghe J, Speeckaert M. Prenanalytical requirements of urinalysis. Biochem Med (Zagreb). 2014;24:89–104.
- European Union. Council Directive 98/83/EC of 3 November 1998 on the quality of water intended for human consumption. Available at: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:31998L0083 [Last accessed March 2017]
- Environment Agency (UK). The Microbiology of Drinking Water (2010) - Part 14 - Methods for the isolation, identification and enumeration of Cryptosporidium oocysts and Giardia cysts. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/316766/Part_14-oct20-234.pdf ([Last accessed March 2017]
- Roche. LightCycler® SeptiFast Test MGRADE. Available at: https://molecular.roche.com/assays/lightcycler-septifast-test-mgrade/[Last accessed March 2017]
- Caicedo HH, Brady ST. Microfluidics: the challenge is to bridge the gap instead of looking for a ‘killer app’. Trends Biotechnol. 2016;34:1–3.
- Mabey D, Peeling RW, Ustianowski A, et al. Diagnostics for the developing world. Nat Rev Microbiol. 2004;2:231–240.
- Urdea M, Penny LA, Olmsted SS, et al. Requirements for high impact diagnostics in the developing world. Nature. 2006;444(Suppl 1):73–79.
- Drain PK, Hyle EP, Noubary F, et al. Diagnostic point-of care tests in resource-limited settings. Lancet Infect Dis. 2014;14:239–249.
- United States Food and Drug Administration. Statistical guidance on reporting results from studies evaluating diagnostic tests. Available at: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm071287.pdf [Last accessed November 2016]
- Replogle WH, Johnson WD, Welch Hoover K. Using evidence to determine diagnostic test efficacy. Worldviews Evid Based Nurs. 2009;6:87–92.
- Bissonnette L, Bergeron MG. The GenePOC platform, a rational solution for extreme point-of-care testing. Micromachines. 2016;7:94.
- Engel N, Wachter K, Pai M, et al. Addressing the challenges of diagnostics demand and supply: insights from an online global health discussion platform. BMJ Glob Health. 2016;1:e000132.
- Taylor BJ, Howell A, Martin KA, et al. A lab-on-chip for malaria diagnosis and surveillance. Malaria J. 2014;13:179.
- Bozko I, Kelley S. A molecular diagnostic platform for use in the physician’s office to treat infectious disease. Am Lab. 2015;47(3):30–31.
- Choi S. Powering point-of-care diagnostic devices. Biotechnol Adv. 2016;34:321–330.
- Chartrand C, Leeflang MMG, Minion J, et al. Accuracy of rapid influenza diagnostic tests - A meta-analysis. Ann Intern Med. 2012;156:500–511.
- Peeling RW, McNerney R. Emerging technologies in point-of-care molecular diagnostics for resource-limited settings. Expert Rev Mol Diagn. 2014;14:525–534.
- Craw P, Balachandran W. Isothermal nucleic acid amplification technologies for point-of-care: a critical review. Lab Chip. 2012;12:2469–2486.
- De Paz HD, Brotons P, Muñoz-Almagro C. Molecular isothermal techniques for combating infectious diseases: towards low-cost point-of-care diagnostics. Expert Rev Mol Diagn. 2014;14:827–843.
- Yan L, Zhou J, Zheng Y, et al. Isothermal amplified detection of DNA and RNA. Mol Biosyst. 2014;10:970–1003.
- Choi JR, Hu J, Feng S, et al. Sensitive biomolecule detection in lateral flow assay with a portable temperature-humidity control device. Biosens Bioelectron. 2016;79:98–107.
- Huang S, Do J, Mahalanabis M, et al. Low cost extraction and isothermal amplification of DNA for infectious diarrhea diagnosis. Plos One. 2013;8(3):e60059.
- Buser JR, Diesburg S, Singleton J, et al. Precision chemical heating for diagnostic devices. Lab Chip. 2015;15:4423–4432.
- Shah KG, Guelig D, Diesburg S, et al. Design of a new type of compact chemical heater for isothermal nucleic acid amplification. Plos One. 2015;10(10):e0139449.
- Liao S-C, Peng J, Mauk MG, et al. Smart cup: a minimally-instrumented smartphone-based point-of-care molecular diagnostic device. Sensors Actuators B Chem. 2016;229:232–238.
- Song J, Mauk MG, Hackett BA, et al. Instrument-free point-of-care molecular detection of Zika virus. Anal Chem. 2016;88:7289–7294.
- Gurrala R, Lang Z, Shepherd L, et al. Novel pH sensing semiconductor for point-of-care detection of HIV-1 viremia. Sci Rep. 2016;6:36000.
- Buser JR, Wollen A, Heiniger EK, et al. Electromechanical cell lysis using a portable audio device: enabling challenging sample preparation at the point-of-care. Lab Chip. 2015;15:1994–1997.
- Laksanasopin T, Guo TW, Nayak S, et al. A smartphone dongle for diagnosis of infectious diseases at the point of care. Sci Transl Med. 2015;7(273):273re1.
- Ahrberg CD, Manz A, Neužil P. Palm-sized device for point-of-care Ebola detection. Anal Chem. 2016;88:4803–4807.
- Brown J, Theis L, Kerr L, et al. A hand-powered, portable, low-cost centrifuge for diagnosing anemia in low-resource settings. Am J Trop Med Hyg. 2011;85:327–332.
- Bhamla MS, Benson B, Chai C, et al. Hand-powered ultralow-cost paper centrifuge. Nat Biomed Eng. 2017;1:0009. DOI:10.1038/s41551-016-0009
- Blick KE. The essential role of information management in point-of-care/critical care testing. Clin Chim Acta. 2001;307:159–168.
- Dingler M, Dietz C, Pfeiffer J, et al. A framework for automatic testing of medical device compatibility. Proceedings of 2015 13th International Conference of Telecommunications (ConTEL), 13-15 July 2015, DOI: 10.1109/ConTEL.2015.7231211
- NCCLS. Point-of-care connectivity; approved standard. NCCLS document POCT1-A. Wayne, PA, USA: NCCLS; 2001.
- Byrdy PC, Mappes RP, Stephans EJ. Point-of-care connectivity standard. Point Care. 2003;2:39–48.
- Abbott Point of Care Data Management Group. Point-of-care testing data management: 5 critical success factors. Point Care. 2007;6:160–162.
- Srinivasan B, Tung S. Development and applications of portable biosensors. J Lab Autom. 2015;20:365–389.
- Vogenberg FR, Barash CI, Pursel M. Personalized medicine - Part 2: ethical, legal, and regulatory issues. P T. 2010;35:624–642.
- Feldman EA. The Genetic Information Nondiscrimination Act (GINA): public policy and medical practice in the age of personalized medicine. J Gen Intern Med. 2012;27:743–746.
- Williams PAH, Woodward AJ. Cybersecurity vulnerabilities in medical devices: a complex environment and multifaceted problem. Med Devices Evidence Res. 2015;8:305–316.
- Colorafi K, Bailey B. It’s time for innovation in the Health Insurance Portability and Accountability Act (HIPAA). JMIR Med Infom. 2016;4(4):e34.
- Kruse CS, Frederick B, Jacobson T, et al. Cybersecurity in healthcare: a systematic review of modern threats and trends. Technol Health Care. 2017;25:1–10.
- United States Department of Health and Human Services. Health Information Privacy. Available at: https://www.hhs.gov/hipaa/ [Last accessed March 2017]
- Tipton SJ, Forkey S, Choi YB. Towards proper authentication methods in electronic medical record access compliant to HIPAA and C.I.A. triangle. J Med Syst. 2016;40:100.
- Baker SD, Knudsen J, Ahmadi DM. Security and safety for medical devices and hospitals. Biomed Instrum Technol. 2013;47:208–211.
- Perakslis ED. Cybersecurity in health care. N Engl J Med. 2014;371:395–397.
- United States Department of Health and human services - Office for Civil Rights. Breach Portal: notice to the Secretary of HHS breach of unsecured protected health information. Available at: https://ocrportal.hhs.gov/ocr/breach/breach_report.jsf [Last accessed March 2017]
- Williams F, Boren SA. The role of the electronic medical record (EMR) in care delivery development in developing countries. Inform Primary Care. 2008;16:139–145.
- Peterson JF, Bowton E, Field JR, et al. Electronic health record design and implementation for pharmacogenomics: a local perspective. Genet Med. 2013;15:833–841.
- Zahabi M, Kaber DB, Swangnetr M. Usability and safety in electronic medical records interface design: a review of recent literature and guideline formulation. Hum Factors. 2015;57:805–834.
- Baysari MT, Lehnbom EC, Li L, et al. The effectiveness of information technology to improve antimicrobial prescribing in hospitals: A systematic review and meta-analysis. Int J Med Inform. 2016;92:15–34.
- Kruse CS, Goswamy R, Raval Y, et al. Challenges and opportunities of big data in health care: a systematic review. JMIR Med Inform. 2016;4(4):e38.
- Peeling RW. Diagnostics in a digital age: an opportunity to strengthen health systems and improve health outcomes. Int Health. 2015;7:384–389.
- United States Food and Drug Administration. Content of premarket submissions for management of cybersecurity in medical devices. Available at: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM356190.pdf [Last accessed January 2017]
- United States Food and Drug Administration. Postmarket management of cybersecurity in medical devices. Available at: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM482022.pdf [Last accessed January 2017]
- Huckle D. Point-of-care diagnostics: an advancing sector with nontechnical issues. Expert Rev Mol Diagn. 2008;8:679–688.
- Huckle D. Point-of-care diagnostics – is this driven by supply or demand? Expert Opin Mol Diagn. 2010;4:189–200.
- European Parliament. Council Directive 93/42/EEC of 14 June 1993 concerning medical devices. Available at: http://eur-lex.europa.eu/legal-content/en/TXT/?uri=CELEX%3A31993L0042 [Last accessed March 2017]
- European Parliament. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Available at: http://eur-lex.europa.eu/legal-content/FR/TXT/?uri=celex%3A31998L0079 [Last accessed March 2017]
- Allied Market Research. Point of care diagnostics market opportunities and technology trends. Available at: www.alliedmarketresearch.com/point-of-care-diagnostics-market [Last accessed November 2016]
- United States Food and Drug Administration. Nucleic acid based tests. Available at: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm330711.htm [Last accessed November 2016]
- Yetisen AK, Akram MS, Lowe CR. Paper-based microfluidic point-of-care diagnostic devices. Lab Chip. 2013;13:2210–2251.
- Bristow CC, Adu-Sarkodie Y, Ondondo RO, et al. Multisite evaluation of a dual human immunodeficiency virus (HIV)/syphilis point-of-care rapid test for simultaneous detection of HIV and syphilis infection. Open Forum Infect Dis. 2014;1(1):ofu015.
- Li J, Macdonald J. Multiplex lateral flow biosensors: technological advances for radically improving point-of-care diagnoses. Biosens Bioelectron. 2016;83:177–192.
- Choi JR, Hu J, Gong Y, et al. An integrated lateral flow for effective DNA amplification and detection at the point of care. Analyst. 2016;141:2930–2939.
- Choi JR, Hu J, Tang R, et al. An integrated paper-based sample-to-answer biosensor for nucleic acid testing at the point of care. Lab Chip. 2016;16:611–621.
- Gervais L, De Rooij N, Delamarche E. Microfluidic chips for point-of-care immunodiagnostics. Adv Mater. 2011;23:H151–H176.
- Bier FF, Schumacher S. Integration in bioanalysis: technologies for point-of-care testing. Adv Biochem Eng Biotechnol. 2013;133:1–14.
- Han KN, Li CA, Seong GH. Microfluidic chips for immunoassays. Annu Rev Anal Chem. 2013;6:119–141.
- Sin MLY, Mach KE, Wong PK, et al. Advances and challenges in biosensor-based diagnosis of infectious diseases. Expert Rev Mol Diagn. 2014;14:225–244.
- Hsieh K, Ferguson BS, Eisenstein M, et al. Integrated electrochemical microsystems for genetic detection of pathogens at point of care. Acc Chem Res. 2015;48:911–920.
- Byrnes S, Thiessen G, Fu E. Progress in the development of paper-based diagnostics for low-resource point-of-care settings. Bioanalysis. 2013;5:2821–2836.
- Chan CPY, Mak WC, Cheng KY, et al. Evidence-based point-of-care diagnostics: current status and emerging technologies. Annu Rev Anal Chem. 2013;6:191–211.
- Coltro WKT, Cheng C-M, Carrilho E, Pereira de Jesus D. Recent advances in low-cost microfluidic platforms for diagnostic applications. Electrophoresis. 2014;35:2309–2324.
- Hu J, Wang S, Wang L, et al. Advances in paper-based point-of-care diagnostics. Biosens Bioelectron. 2014;54:585–597.
- Phillips ST, Lewis GG. The expanding role of paper in point-of-care diagnostics. Expert Rev Mol Diagn. 2014;14:123–125.
- Choi JR, Tang R, Wang S, et al. Paper-based sample-to-answer molecular diagnostic platform for point-of-care diagnostics. Biosens Bioelectron. 2015;74:427–439.
- Rodriguez NM, Wong WS, Liu L, et al. A fully integrated paperfluidic molecular diagnostic chip for the extraction, amplification, and detection of nucleic acid from clinical samples. Lab Chip. 2016;16:753–763.
- Vashist SK, Mudanyali O, Schneider EM, et al. Cellphone-based devices for bioanalytical sciences. Anal Bioanal Chem. 2014;406:3263–3277.
- Rasooly R, Bruck HA, Prickril B, et al. Improving the sensitivity and functionality of mobile webcam-based fluorescence detectors for point-of-care diagnostics in global health. Diagnostics. 2016;6:19.
- Truong A-T, Abraham A, Kost GJ, et al. Smartphone-enabled point of care. In: Kost GJ, Corbin CM, Editors. Global point of care - Strategies for disasters, emergencies, and public health resilience. Washington: AACC Press; 2015. p. 177–187.
- Kwon L, Long KD, Wan Y, et al. Medical diagnostics with mobile devices: comparison of intrinsic and extrinsic sensing. Biotechnol Adv. 2016;34:291–304.
- Romeo A, Leung TS, Sánchez S. Smart biosensors for multiplex and fully integrated point-of-care diagnostics. Lab Chip. 2016;16:1957–1961.
- Krishna S, Boren SA, Balas EA. Healthcare via cell phones: a systematic review. Telemed J E Health. 2009;15:231–240.
- Erickson D, O’Dell D, Jiang L, et al. Smartphone technology can be transformative to the deployment of lab-on-chip diagnostics. Lab Chip. 2014;14:3159–3164.
- Martinez AW, Phillips ST, Carrilho E, et al. Simple telemedicine for developing regions: camera phones and paper-based microfluidic devices for real-time, off-site diagnosis. Anal Chem. 2008;80:3699–3707.
- Liu X, Lin T-Y, Lillehoj PB. Smartphones for cell and biomolecular detection. Ann Biomed Eng. 2014;42:2205–2217.
- Bates M, Zumla A. Rapid infectious diseases diagnostics using Smartphones. Ann Transl Med. 2015;3(15):215.
- Xu X, Akay A, Wei H, et al. Advances in smartphone-based point-of-care diagnostics. Proc IEEE. 2015;103:236–247.
- Linder E, Grote A, Varjo S, et al. On-chip imaging of Schistosoma haematobium eggs in urine for diagnosis by computer vision. Plos Negl Trop Dis. 2013;7:e2547.
- Stemple CC, Angus SV, Park TS, et al. Smartphone-based optofluidic lab-on-a-chip for detecting pathogens from blood. J Lab Autom. 2014;19:35–41.
- Ephraim RKD, Duah E, Cybulski JS, et al. Diagnosis of Schistosoma haematobium infection with a mobile phone-mounted Foldscope and a reversed-lens CellScope in Ghana. Am J Trop Med Hyg. 2015;92:1253–1256.
- Coulibaly JT, Ouattara M, D’Ambrosio MV, et al. Accuracy of mobile phone and handheld light microscopy for the diagnosis of schistosomiasis and intestinal protozoa infections in Côte d’Ivoire. Plos Negl Trop Dis. 2016;10(6):e0004768.
- Yu H, Tan Y, Cunningham BT. Smartphone fluorescence spectroscopy. Anal Chem. 2014;86:8805–8813.
- Ming K, Kim J, Biondi MJ, et al. Integrated quantum dot barcode smartphone optical device for wireless multiplexed diagnosis of infected patients. ACS Nano. 2015;9:3060–3074.
- Jiang L, Mancuso M, Lu Z, et al. Solar thermal polymerase chain reaction for smartphone-assisted molecular diagnostics. Sci Rep. 2014;4:4137.
- Shu B, Zhang C, Xing D. A handheld flow genetic analysis (FGAS): towards rapid, sensitive, quantitative and multiplex molecular diagnosis at the point-of-care level. Lab Chip. 2015;15:2597–2605.
- Priye A, Wong S, Bi Y, et al. Lab-on-a-drone: toward pinpoint deployment of smartphone-enabled nucleic acid-based diagnostics for mobile health care. Anal Chem. 2016;88:4651–4660.
- United States Food and Drug Administration. Mobile medical applications. Available at: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM263366.pdf [Last accessed November 2016]
- Wang S, Chinnasamy T, Lifson MA, et al. Flexible substrate-based devices for point-care diagnostics. Trends Biotechnol. 2016;34:909–921.
- McLister A, McHugh J, Cundell J, et al. New developments in smart bandage technologies for wound diagnostics. Adv Mater. 2016;28:5732–5737.
- Mak WC, Cheung KY, Orban J, et al. Surface-engineered contact lens as an advanced theranostic platform for modulation and detection of viral infection. ACS Appl Mater Interfaces. 2015;7:25487–25494.
- Abbott Point of Care. i-STAT Alinity website. Available at: http://www.abbottpointofcare.com/en-int/i-stat-alinity/overview [Last accessed November 2016]
- Nougairede A, Ninove L, Zandotti C, et al. Point of care strategy for rapid diagnosis of novel A/H1N1 influenza virus. Plos One. 2010;5:e9215.
- Cohen-Bacrie S, Ninove L, Nougairède A, et al. Revolutionizing clinical microbiology laboratory organization in hospitals with in situ point-of-care. Plos One. 2011;6:e22403.
- Abbott Point of Care. i-STAT® handheld website Available at: http://www.abbottpointofcare.com/en-int/products-services/istat-handheld [Last accessed November 2016]
- MacLeod JA, Nemeth AC, Dicke WC, et al. Fast, sensitive point of care electrochemical molecular system for point mutation and selection agent detection. Lab Chip. 2016;16:2513–2520.
- Roine A, Saviauk T, Kumpulainen P, et al. Rapid and accurate detection of urinary pathogens by mobile IMS-based electronic nose: a proof-of-principle study. Plos One. 2014;9(12):e114279.
- Lafleur LK, Bishop JD, Heininger EK, et al. A rapid, instrument-free, sample-to-result nucleic acid amplification test. Lab Chip. 2016;16:3777–3787.
- Castan P, De Pablo A, Fernández-Romero N, et al. Point-of-care system for detection of Mycobacterium tuberculosis and rifampin resistance in sputum samples. J Clin Microbiol. 2014;52:502–507.
- Shenai S, Armstrong DT, Valli E, et al. Analytical and clinical evaluation of the Epistem Genedrive assay for detection of Mycobacterium tuberculosis. J Clin Microbiol. 2016;54:1051–1057.
- Neely LA, Audeh M, Phung NA, et al. T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med. 2013;5(182):182ra54.
- Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2014;60:892–899.
- Pfaller MA, Wolk DM, Lowery TJ. T2MR and T2Candida: novel technology for rapid diagnosis of candidemia and invasive candidiasis. Future Microbiol. 2015;11:103–117.
- Huletsky A, Giroux R, Rossbach V, et al. New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. J Clin Microbiol. 2004;42:1875–1884.